发明授权
US07977460B2 Compositions comprising coagulation factors IXA and VIII for the treatment of haemophilia A or B
失效
包含用于治疗血友病A或B的凝血因子IXA和VIII的组合物
- 专利标题： Compositions comprising coagulation factors IXA and VIII for the treatment of haemophilia A or B
- 专利标题（中）： 包含用于治疗血友病A或B的凝血因子IXA和VIII的组合物
-
申请号： US10829042申请日： 2004-04-21
-
公开(公告)号： US07977460B2公开(公告)日： 2011-07-12
- 发明人: Trevor Barrowcliffe
- 申请人： Trevor Barrowcliffe
- 申请人地址： GB Hertfordshire
- 专利权人： National Institute for Biological Standards and Control
- 当前专利权人： National Institute for Biological Standards and Control
- 当前专利权人地址： GB Hertfordshire
- 代理机构： Vedder Price P.C.
- 代理商 Thomas J. Kowalski; Deborah L. Lu
- 优先权： GB0311465.9 20030519; GB0318533.7 20030808
- 主分类号： A61K38/39
- IPC分类号： A61K38/39
摘要：
The present invention relates to the use of FIXa and FVIII in the preparation of a composition for the treatment of haemophilia A or haemophilia B in a subject which does not present with anti-FVIII antibodies. The present invention further relates to a composition comprising FIXa and a composition comprising FVIII for simultaneous, simultaneous separate or sequential use in the treatment of haemophilia A or haemophilia B in a subject which does not present with anti-FVIII antibodies.
公开/授权文献
- US20040235737A1 Composition 公开/授权日：2004-11-25
信息查询
IPC分类:
